Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Otitis Externa D010032 8 associated lipids
Burns D002056 34 associated lipids
Body Weight D001835 333 associated lipids
Peritonitis D010538 38 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Vaginitis D014627 6 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Dermatomycoses D003881 17 associated lipids
Pregnancy Complications, Infectious D011251 11 associated lipids
Aspergillosis D001228 5 associated lipids
Leishmaniasis D007896 19 associated lipids
HIV Seropositivity D006679 15 associated lipids
Influenza, Human D007251 11 associated lipids
Vaginosis, Bacterial D016585 10 associated lipids
Candidiasis, Oral D002180 11 associated lipids
Mycoses D009181 18 associated lipids
Gonorrhea D006069 7 associated lipids
Xerostomia D014987 6 associated lipids
AIDS-Related Opportunistic Infections D017088 9 associated lipids
Urethritis D014526 9 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Blastomycosis D001759 5 associated lipids
Candidemia D058387 2 associated lipids
Per page 10 20 50 | Total 25

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Graves JS et al. Embryonic chick allantois: functional isolation and development of sodium transport. 1986 Am. J. Physiol. pmid:3777157
Chamberlin ME and Mandel LJ Substrate support of medullary thick ascending limb oxygen consumption. 1986 Am. J. Physiol. pmid:3532824
Kirk RG et al. Electron probe microanalysis of red blood cells. I. Methods and evaluation. 1978 Am. J. Physiol. pmid:727247
Gesek FA and Friedman PA Sodium entry mechanisms in distal convoluted tubule cells. 1995 Am. J. Physiol. pmid:7840252
Gruwel ML et al. Na(+)-K(+)-ATPase in endothelial cell energetics: 23Na nuclear magnetic resonance and calorimetry study. 1995 Am. J. Physiol. pmid:7840283
Gaudio KM et al. Metabolic alterations in proximal tubule suspensions obtained from ischemic kidneys. 1989 Am. J. Physiol. pmid:2551186
Fujii Y and Katz AI Direct Na+-K+ pump stimulation by K+ in cortical collecting tubules: a mechanism for early renal K+ adaptation. 1989 Am. J. Physiol. pmid:2552833
Hillyard SD et al. K+ transport and capacitance of the basolateral membrane of the larval frog skin. 1997 Am. J. Physiol. pmid:9435506
Chalfant ML et al. Regulation of epithelial Na+ channels from M-1 cortical collecting duct cells. 1996 Am. J. Physiol. pmid:8898016
Negrete HO et al. Permeability properties of the intact mammalian bladder epithelium. 1996 Am. J. Physiol. pmid:8898019
Knauf PA and Mann NA Location of the chloride self-inhibitory site of the human erythrocyte anion exchange system. 1986 Am. J. Physiol. pmid:2425624
Grasset E et al. Epithelial properties of human colonic carcinoma cell line Caco-2: electrical parameters. 1984 Am. J. Physiol. pmid:6476109
Charney AN and Egnor RW Membrane site of action of CO2 on colonic sodium absorption. 1989 Am. J. Physiol. pmid:2493740
Lavelle JP et al. Disruption of guinea pig urinary bladder permeability barrier in noninfectious cystitis. 1998 Am. J. Physiol. pmid:9458841
Knauf PA et al. Eosin-5-maleimide inhibits red cell Cl- exchange at a noncompetitive site that senses band 3 conformation. 1993 Am. J. Physiol. pmid:7684558
O'Neill WC Cl-dependent K transport in a pure population of volume-regulating human erythrocytes. 1989 Am. J. Physiol. pmid:2705517
Steagall WK et al. Type II protein kinase A regulates CFTR in airway, pancreatic, and intestinal cells. 1998 Am. J. Physiol. pmid:9530114
Jacobs WR et al. Role of cytosolic Ca in renal tubule damage induced by anoxia. 1991 Am. J. Physiol. pmid:2003577
Liedtke CM and Cole T Antisense oligodeoxynucleotide to PKC-delta blocks alpha 1-adrenergic activation of Na-K-2Cl cotransport. 1997 Am. J. Physiol. pmid:9374649
Yanase M and Handler JS Activators of protein kinase C inhibit sodium transport in A6 epithelia. 1986 Am. J. Physiol. pmid:2420202
Soltoff SP et al. Amiloride analogues inhibit proximal tubule metabolism. 1986 Am. J. Physiol. pmid:2422947
Seri I et al. Locally formed dopamine inhibits Na+-K+-ATPase activity in rat renal cortical tubule cells. 1988 Am. J. Physiol. pmid:2845809
Park CS et al. Role of carboxyl group in Na+-entry step at apical membrane of toad urinary bladder. 1983 Am. J. Physiol. pmid:6140855
DuVall MD et al. Hydrogen peroxide inhibits cAMP-induced Cl- secretion across colonic epithelial cells. 1998 Am. J. Physiol. pmid:9814980
Ribeiro CP and Mandel LJ Parathyroid hormone inhibits proximal tubule Na(+)-K(+)-ATPase activity. 1992 Am. J. Physiol. pmid:1311522
Rosen R and Friedman AH Successfully treated postoperative Candida parakrusei endophthalmitis. 1973 Am. J. Ophthalmol. pmid:4355255
Mostafa MS Aspergillus niger infection of the eye. 1966 Am. J. Ophthalmol. pmid:5957897
Ross HW and Laibson PR Keratomycosis. 1972 Am. J. Ophthalmol. pmid:4559777
Michelson PE et al. Endogenous Candida endophthalmitis leading to bilateral corneal perforation. 1975 Am. J. Ophthalmol. pmid:1081343
Palmer EA Endogenous Candida endophthalmitis in infants. 1980 Am. J. Ophthalmol. pmid:6966132
ROBERTS SS Nystatin in monilia keratoconjunctivitis; a case report. 1957 Am. J. Ophthalmol. pmid:13435334
Ernest JT and Rippon JW Keratitis due to Allescheria boydii (Monosporium apiospermum). 1966 Am. J. Ophthalmol. pmid:5334519
Ellison AC et al. Chemotherapy of experimental keratomycosis. 1969 Am. J. Ophthalmol. pmid:5352600
Friedrich EG Vaginitis. 1985 Am. J. Obstet. Gynecol. pmid:3873872
Therapy of candidal vaginitis: the effect of eliminating intestinal Candida. Nystatin Multicenter Study Group. 1986 Am. J. Obstet. Gynecol. pmid:3529970
Dan M Severe vulvovaginitis associated with intravaginal nystatin therapy. 2001 Am. J. Obstet. Gynecol. pmid:11483943
Proost JM et al. Miconazole in the treatment of mycotic vulvovaginitis. 1972 Am. J. Obstet. Gynecol. pmid:4551031
Orley J Nystatin versus boric acid powder in vulvovaginal candidiasis. 1982 Am. J. Obstet. Gynecol. pmid:7148934
Van Slyke KK et al. Treatment of vulvovaginal candidiasis with boric acid powder. 1981 Am. J. Obstet. Gynecol. pmid:7282789
Diddle AW Trichomonas vaginalis: resistance to metronidazole. 1967 Am. J. Obstet. Gynecol. pmid:5182244
Cohen L Is more than one application of an antifungal necessary in the treatment of acute vaginal candidiasis? 1985 Am. J. Obstet. Gynecol. pmid:3895961
Silverman M and Okun R Oxytetracycline-nystatin in the prevention of candidal vaginitis. 1971 Am. J. Obstet. Gynecol. pmid:4937726
Fox LP Fatal superinfection with monilia in gynecological surgery. 1971 Am. J. Obstet. Gynecol. pmid:5103383
Van Cutsem J The in vitro activity of terconazole against yeasts: its topical long-acting therapeutic efficacy in experimental vaginal candidiasis in rats. 1991 Am. J. Obstet. Gynecol. pmid:1951575
Culbertson C MONISTAT: a new fungicide for treatment of vulvovaginal candidiasis. 1974 Am. J. Obstet. Gynecol. pmid:4429114
Sanchez S et al. Intravaginal metronidazole gel versus metronidazole plus nystatin ovules for bacterial vaginosis: a randomized controlled trial. 2004 Am. J. Obstet. Gynecol. pmid:15592270
HARRIS LJ Further observations on a simple procedure to eliminate thrush from hospital nurseries. 1960 Am. J. Obstet. Gynecol. pmid:14399978
KAYSER HL et al. The use of nystatin in the treatment of vaginal candidiasis in pregnancy. 1957 Am. J. Obstet. Gynecol. pmid:13435297
Lee WM et al. Refractory esophageal candidiasis associated with a low molecular weight plasma inhibitor of T-lymphocyte function. 1986 Am. J. Med. Sci. pmid:3487248
Bodey GP et al. Protected environment-prophylactic antibiotic program for malignant lymphoma. Randomized trial during chemotherapy to induce remission. 1979 Am. J. Med. pmid:84532